The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial

EuroIntervention 2010;5:917-924 - DOI10.4244/EIJV5I8A155.

1. University at Buffalo, Buffalo, NY, USA; 2. Hoag Hospital, Newport Beach, CA, USA; 3. HELIOS Heart Center, Siegburg, Germany; 4. Allegheny General Hospital, Pittsburgh, PA, USA; 5. PinnacleHealth Heart and Vascular Institute, Harrisburg Hospital, Centr

Aims: To investigate long-term outcomes achieved in high-surgical-risk patients and other clinically-relevant subgroups after carotid stenting with the NexStent and Filterwire EX/EZ devices

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Between-centre reproducibility of volumetric intravascular ultrasound radiofrequency-based analyses in mild-tomoderate coronary atherosclerosis: an international multicentre study